Thrivent Financial for Lutherans’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-30,009
Closed -$123K 2596
2024
Q1
$123K Hold
30,009
﹤0.01% 2485
2023
Q4
$126K Sell
30,009
-1,465
-5% -$6.15K ﹤0.01% 2458
2023
Q3
$136K Sell
31,474
-54,953
-64% -$237K ﹤0.01% 2403
2023
Q2
$570K Sell
86,427
-2,868
-3% -$18.9K ﹤0.01% 2132
2023
Q1
$606K Sell
89,295
-1,772
-2% -$12K ﹤0.01% 2047
2022
Q4
$673K Sell
91,067
-421
-0.5% -$3.11K ﹤0.01% 1965
2022
Q3
$904K Buy
91,488
+35,989
+65% +$356K ﹤0.01% 1747
2022
Q2
$605K Buy
55,499
+10,145
+22% +$111K ﹤0.01% 2007
2022
Q1
$513K Buy
45,354
+15
+0% +$170 ﹤0.01% 2183
2021
Q4
$711K Buy
45,339
+366
+0.8% +$5.74K ﹤0.01% 2044
2021
Q3
$771K Sell
44,973
-449
-1% -$7.7K ﹤0.01% 1976
2021
Q2
$977K Buy
45,422
+337
+0.7% +$7.25K ﹤0.01% 1859
2021
Q1
$677K Sell
45,085
-185
-0.4% -$2.78K ﹤0.01% 2094
2020
Q4
$595K Sell
45,270
-132
-0.3% -$1.74K ﹤0.01% 2055
2020
Q3
$439K Hold
45,402
﹤0.01% 2032
2020
Q2
$519K Buy
45,402
+701
+2% +$8.01K ﹤0.01% 1892
2020
Q1
$463K Buy
44,701
+2,231
+5% +$23.1K ﹤0.01% 1756
2019
Q4
$697K Buy
42,470
+189
+0.4% +$3.1K ﹤0.01% 1700
2019
Q3
$561K Buy
42,281
+981
+2% +$13K ﹤0.01% 1768
2019
Q2
$582K Buy
41,300
+1,214
+3% +$17.1K ﹤0.01% 1735
2019
Q1
$738K Buy
40,086
+3,012
+8% +$55.5K ﹤0.01% 1571
2018
Q4
$969K Buy
37,074
+815
+2% +$21.3K ﹤0.01% 1173
2018
Q3
$832K Buy
+36,259
New +$832K ﹤0.01% 1409
2016
Q1
Sell
-93,060
Closed -$866K 2029
2015
Q4
$866K Buy
+93,060
New +$866K ﹤0.01% 1115